1887

Abstract

Protection against influenza virus infection and antibody responses in mice vaccinated with plasmid DNAs encoding haemagglutinin (HA), neuraminidase (NA) and nucleoprotein (NP) were compared among BALB/c (H-2), B10 (H-2) and C3H (H-2 ) mice. Mice were inoculated with each DNA construct twice, 3 weeks apart, at a dose of 1 μg per mouse by particle-mediated DNA transfer (gene gun) to the epidermis. They were challenged with a lethal dose of the homologous virus 7 days after the second vaccination. NA-DNA provided significant protection in all strains of mouse, whereas HA-DNA afforded significant protection only in BALB/c mice. The serum antibody titres against NA or HA molecules in BALB/c, C3H and B10 mice were high, intermediate and low, respectively. NP-DNA failed to provide protection in any strain of mouse, and elicited low titres of anti-NP antibodies. These results suggest that NA-DNA can be used as a vaccine component to provide effective protection against influenza virus infection in various strains of mouse.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-80-10-2559
1999-10-01
2021-03-04
Loading full text...

Full text loading...

/deliver/fulltext/jgv/80/10/0802559a.html?itemId=/content/journal/jgv/10.1099/0022-1317-80-10-2559&mimeType=html&fmt=ahah

References

  1. Ada G. L., Jones P. D. 1986; The immune response to influenza infection. Current Topics in Microbiology and Immunology 128:1–54
    [Google Scholar]
  2. Brodsky F. M., Guagliardi L. 1991; The cell biology of antigen processing and presentation. Annual Review of Immunology 9:707–744
    [Google Scholar]
  3. Chen Z., Sahashi Y., Matsuo K., Asanuma H., Takahashi H., Iwasaki T., Suzuki Y., Aizawa C., Kurata T., Tamura S.-I. 1998; Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza. Vaccine 16:1544–1549
    [Google Scholar]
  4. Chen Z., Matsuo K., Asanuma H., Takahashi H., Iwasaki T., Suzuki Y., Aizawa C., Kurata T., Tamura S.-I. 1999; Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs. Vaccine 17:653–659
    [Google Scholar]
  5. Couch R. B., Kasel J. A., Gerin J. L., Schulman J. L., Kilbourne E. D. 1974; Induction of partial immunity to influenza by a neuraminidase-specific vaccine. Journal of Infectious Diseases 129:411–420
    [Google Scholar]
  6. Deroo T., Jou W. M., Fiers W. 1996; Recombinant neuraminidase vaccine protects against lethal influenza. Vaccine 14:561–569
    [Google Scholar]
  7. Donnelly J. J., Friedman A., Martinez D., Montgomery D. L., Shiver J. W., Motzel S. L., Ulmer J. B., Liu M. A. 1995; Preclinical efficacy of a prototype DNA vaccine: enhanced protection against antigenic drift in influenza virus. Nature Medicine 1:583–587
    [Google Scholar]
  8. Donnelly J. J., Ulmer J. B., Shiver J. W., Liu M. A. 1997; DNA vaccine. Annual Review of Immunology 15:617–648
    [Google Scholar]
  9. Feltquate D. W., Heaney S., Webster R. G., Robinson H. L. 1997; Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. Journal of Immunology 158:2278–2284
    [Google Scholar]
  10. Fu T. M., Friedman A., Ulmer J. B., Lui M. A., Donnelly J. J. 1997; Protective cellular immunity: cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization. Journal of Virology 71:2715–2721
    [Google Scholar]
  11. Fynan E. F., Webster R. G., Fuller D. H., Haynes J. R., Santoro J. C., Robinson H. L. 1993; DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. Proceedings of the National Academy of Sciences, USA 90:11478–11482
    [Google Scholar]
  12. Hirabayashi Y., Tamura S.-I., Suzuki Y., Nagamine T., Aizawa C., Shimana K., Kurata T. 1991; H-2-unrestricted adjuvant effect of cholera toxin B subunit on murine antibody response to influenza virus haemagglutinin. Immunology 72:329–335
    [Google Scholar]
  13. Johansson B. E., Kilbourne E. D. 1994; Immunization with purified N1 and N2 influenza virus neuraminidases demonstrates cross- reactivity without antigenic competition. Proceedings of the National Academy of Sciences, USA 91:2358–2361
    [Google Scholar]
  14. Johansson B. E., Kilbourne E. D. 1996; Immunization with dissociated neuraminidase, matrix, and nucleoproteins from influenza A virus eliminates cognate help and antigenic competition. Virology 225:136–144
    [Google Scholar]
  15. Johansson B. E., Moran T. M., Kilbourne E. D. 1987; Antigen-presenting B cells and T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins. Proceedings of the National Academy of Sciences, USA 84:6869–6873
    [Google Scholar]
  16. Johansson B. E., Matthews J. T., Kilbourne E. D. 1998; Supplementation of conventional influenza A vaccine with purified viral neuraminidase results in a balanced and broadened immune response. Vaccine 16:1009–1015
    [Google Scholar]
  17. Jones P. P., Murphy D. B., McDevitt H. O. 1981; Variable synthesis and expression of Eα and Ae (Eβ) Ia polypeptide chains in mice of different H-2 haplotypes. Immunogenetics 12:321–337
    [Google Scholar]
  18. Khan M. W., Gallagher M., Bucher D., Cerini C. P., Kilbourne E. D. 1982; Detection of influenza virus neuraminidase-specific antibodies by an enzyme-linked immunosorbent assay. Journal of Clinical Microbiology 16:115–122
    [Google Scholar]
  19. Kilbourne E. D., Johansson B. E., Grajower B. 1990; Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins. Proceedings of the National Academy of Sciences, USA 87:786–790
    [Google Scholar]
  20. Kodihalli S., Haynes J. R., Robinson H. L., Webster R. G. 1997; Cross-protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin. Journal of Virology 71:3391–3396
    [Google Scholar]
  21. Macgregor R. R., Boyer J. D., Ugen K. E., Lacy K. E., Gluckman S. J., Bagarazzi M. L., Chattergoon M. A., Baine Y., Higgins T. J., Ciccarelli R. B., Coney L. R., Ginsberb R. S., Weiner D. B. 1998; First human trial of a DNA-based vaccine for treatment of human immunodeficiency virus type 1 infection: safety and host response. Journal of Infectious Diseases 178:92–100
    [Google Scholar]
  22. Niwa H., Yamamura K., Miyazaki J. 1991; Efficient selection for high- expression transfectants with a novel eukaryotic vector. Gene 108:193–200
    [Google Scholar]
  23. Ozato K., Lunney J. K., El-Gamil M., Sachs D. H. 1980; Evidence for absence of I-E/C antigen expression on the cell surface in mice of the H-2b or H2s haplotypes. Journal of Immunology 125:940–945
    [Google Scholar]
  24. Pertmer T. M., Roberts T. R., Haynes J. R. 1996; Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. Journal of Virology 70:6119–6125
    [Google Scholar]
  25. Phelan M. A., Mayner R. E., Bucker D. J., Ennis F. A. 1980; Purification of influenza virus glycoproteins for the preparation and standardization of immunological potency testing reagents. Journal of Biological Standardization 8:233–242
    [Google Scholar]
  26. Potier M., Mameli L., Belisle M., Dallaire L., Melancon S. B. 1979; Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-α-d- N -acetylneuraminate) substrate. Analytical Biochemistry 94:287–296
    [Google Scholar]
  27. Ramsay A. J., Leong K. H., Ramshaw I. A. 1997; DNA vaccination against virus infection and enhancement of antiviral immunity following consecutive immunization with DNA and viral vectors. Immunology and Cell Biology 75:382–388
    [Google Scholar]
  28. Raz E., Carson D. A., Parker S. E. and others 1994; Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proceedings of the National Academy of Sciences, USA 91:9519–9523
    [Google Scholar]
  29. Robinson H. L., Hunt L. A., Webster R. G. 1993; Protection against a lethal influenza virus challenge by immunization with a haemmagglutinin- expressing plasmid DNA. Vaccine 11:957–960
    [Google Scholar]
  30. Shreffler D. C., David C. S. 1975; The H-2 majority histocompatibility complex and the I immune response region: genetic variation, function, and organization. Advances in Immunology 20:125–195
    [Google Scholar]
  31. Tamura S.-I., Ito Y., Asanuma H., Hirabayashi Y., Suzuki Y., Nagamine T., Aizawa C., Kurata T. 1992; Cross-protection against influenza virus infection afforded by trivalent inactivated vaccines inoculated intranasally with cholera toxin B subunit. Journal of Immunology 149:981–988
    [Google Scholar]
  32. Tamura S.-I., Miyata K., Matsuo K., Asanuma H., Takahashi H., Nakajima K., Suzuki Y., Aizawa C., Kurata T. 1996; Acceleration of influenza virus clearance by Th1 cells in the nasal site of mice immunized intranasally with adjuvant-combined recombinant nucleoprotein. Journal of Immunology 156:3892–3900
    [Google Scholar]
  33. Tighe H., Corr M., Roman M., Raz E. 1998; Gene vaccination: plasmid DNA is more than just a blueprint. Immunology Today 19:89–97
    [Google Scholar]
  34. Torres C. A. T., Iwasaki A., Barber B. H., Robinson H. L. 1997; Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. Journal of Immunology 158:4529–4532
    [Google Scholar]
  35. Ulmer J. B., Donnelly J. J., Parker S. E., Rhodes G. H., Felgner P. L., Dwarki V. J., Gromkowski S. H., Deck R. R., DeWitt C. M., Friedman A., Hawe L. A., Leander K. R., Martinez D., Perry H. C., Shiver J. W., Montgomery D. L., Liu M. A. 1993; Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259:1745–1749
    [Google Scholar]
  36. Ulmer J. B., Deck R. R., DeWitt C. M., Friedman A., Donnelly J. J., Liu M. A. 1994; Protective immunity by intramuscular injection of low doses of influenza virus DNA vaccines. Vaccine 12:1541–1544
    [Google Scholar]
  37. Webster R. G., Fynan E. F., Santoro J. C., Robinson H. 1994; Protection of ferrets against influenza challenge with a DNA vaccine to the haemmagglutinin. Vaccine 12:1495–1498
    [Google Scholar]
  38. Yetter R. A., Lehrer S., Ramphal R., Small P. A. Jr 1980; Outcome of influenza infection: effect of site of initial infection and heterotypic immunity. Infection and Immunity 29:654–662
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-80-10-2559
Loading
/content/journal/jgv/10.1099/0022-1317-80-10-2559
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error